5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one

C29H42N8O3 — CID 118558803

IUPAC5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one
SMILESCC1CCC(C(C)n2c(N3CCOC4CCCC43)nc3nc(-c4n[nH]c(=O)o4)nc(N[C@H](C)C4CCC4)c32)CC1
InChIInChI=1S/C29H42N8O3/c1-16-10-12-20(13-11-16)18(3)37-23-24(30-17(2)19-6-4-7-19)31-26(27-34-35-29(38)40-27)32-25(23)33-28(37)36-14-15-39-22-9-5-8-21(22)36/h16-22H,4-15H2,1-3H3,(H,35,38)(H,30,31,32)/t16?,17-,18?,20?,21?,22?/m1/s1
InChIKeyJWRFCMPSRZBFJE-WQDCEBPSSA-N
MW550.71 g/mol
LogP4.92
Rot. Bonds7

About 5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one

5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one (PubChem CID 118558803) has the molecular formula C29H42N8O3 and a molecular weight of 550.71 g/mol. Its IUPAC name is 5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one.

Molecular Properties

Compound Name5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one
PubChem CID118558803
Molecular FormulaC29H42N8O3
Molecular Weight550.71 g/mol
Exact Mass550.34
IUPAC Name5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one
SMILESCC1CCC(C(C)n2c(N3CCOC4CCCC43)nc3nc(-c4n[nH]c(=O)o4)nc(N[C@H](C)C4CCC4)c32)CC1
InChIInChI=1S/C29H42N8O3/c1-16-10-12-20(13-11-16)18(3)37-23-24(30-17(2)19-6-4-7-19)31-26(27-34-35-29(38)40-27)32-25(23)33-28(37)36-14-15-39-22-9-5-8-21(22)36/h16-22H,4-15H2,1-3H3,(H,35,38)(H,30,31,32)/t16?,17-,18?,20?,21?,22?/m1/s1
InChIKeyJWRFCMPSRZBFJE-WQDCEBPSSA-N
XLogP4.92
TPSA126.99 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds7
Heavy Atoms40
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500550.71
LogP ≤ 54.92
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Analyze 5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one?
The IUPAC name of 5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one (CID 118558803) is 5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one.
What is the SMILES notation for 5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one?
The canonical SMILES for 5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one is CC1CCC(C(C)n2c(N3CCOC4CCCC43)nc3nc(-c4n[nH]c(=O)o4)nc(N[C@H](C)C4CCC4)c32)CC1.
What is the InChIKey of 5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one?
The InChIKey is JWRFCMPSRZBFJE-WQDCEBPSSA-N. The full InChI is InChI=1S/C29H42N8O3/c1-16-10-12-20(13-11-16)18(3)37-23-24(30-17(2)19-6-4-7-19)31-26(27-34-35-29(38)40-27)32-25(23)33-28(37)36-14-15-39-22-9-5-8-21(22)36/h16-22H,4-15H2,1-3H3,(H,35,38)(H,30,31,32)/t16?,17-,18?,20?,21?,22?/m1/s1.
What are the key properties of 5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one?
5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one has a molecular weight of 550.71 g/mol, XLogP of 4.92, 7 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[8-(3,4a,5,6,7,7a-hexahydro-2H-cyclopenta[b][1,4]oxazin-4-yl)-6-[[(1R)-1-cyclobutylethyl]amino]-7-[1-(4-methylcyclohexyl)ethyl]purin-2-yl]-3H-1,3,4-oxadiazol-2-one is sourced from PubChem (CID 118558803), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).